Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1990 1
1992 2
1995 1
2000 1
2001 1
2002 1
2003 1
2006 2
2007 2
2008 6
2009 5
2010 7
2011 2
2012 2
2013 7
2014 4
2015 18
2016 9
2017 13
2018 6
2019 10
2020 5
2021 9
2022 6
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Bevacizumab (Avastin) in cancer treatment: A review of 15 years of clinical experience and future outlook.
Garcia J, Hurwitz HI, Sandler AB, Miles D, Coleman RL, Deurloo R, Chinot OL. Garcia J, et al. Cancer Treat Rev. 2020 Jun;86:102017. doi: 10.1016/j.ctrv.2020.102017. Epub 2020 Mar 26. Cancer Treat Rev. 2020. PMID: 32335505 Free article. Review.
Initially approved for treatment of metastatic colorectal cancer in combination with chemotherapy, its indications now include metastatic breast cancer, non-small-cell lung cancer, glioblastoma, renal cell carcinoma, ovarian cancer and cervical cancer. …
Initially approved for treatment of metastatic colorectal cancer in combination with chemotherapy, its indications now include metastatic br …
Glioblastoma Multiforme: The Latest Diagnostics and Treatment Techniques.
Czarnywojtek A, Borowska M, Dyrka K, Van Gool S, Sawicka-Gutaj N, Moskal J, Kościński J, Graczyk P, Hałas T, Lewandowska AM, Czepczyński R, Ruchała M. Czarnywojtek A, et al. Pharmacology. 2023;108(5):423-431. doi: 10.1159/000531319. Epub 2023 Jul 17. Pharmacology. 2023. PMID: 37459849 Free article. Review.
Oncological therapy includes individual analysis of the properties of a tumour and targeted therapy using small-molecule inhibitors. ...In addition, IMI is based on the concept of oncolytic virus-induced immunogenic tumour cell death. SUMMARY: In this …
Oncological therapy includes individual analysis of the properties of a tumour and targeted therapy using small-molecul …
Emerging treatment strategies for glioblastoma multiforme.
Carlsson SK, Brothers SP, Wahlestedt C. Carlsson SK, et al. EMBO Mol Med. 2014 Nov;6(11):1359-70. doi: 10.15252/emmm.201302627. EMBO Mol Med. 2014. PMID: 25312641 Free PMC article. Review.
Glioblastoma multiforme (GBM) is the deadliest form of brain tumor with a more than 90% 5-year mortality. ...The discussion will include biomarkers, tumor imaging, novel therapies such as monoclonal antibodies and small-molecule inhibitors, and the heterogene …
Glioblastoma multiforme (GBM) is the deadliest form of brain tumor with a more than 90% 5-year mortality. ...The discussion will incl …
Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O, Yetkin-Arik B, de Gooijer MC, Wesseling P, Wurdinger T, de Vries HE. van Tellingen O, et al. Drug Resist Updat. 2015 Mar;19:1-12. doi: 10.1016/j.drup.2015.02.002. Epub 2015 Mar 6. Drug Resist Updat. 2015. PMID: 25791797 Review.
Even though the BBTB is considered 'leaky' in the core part of glioblastomas, in large parts of glioblastomas and, even more so, in lower grade diffuse gliomas the BBTB more closely resembles the intact blood-brain barrier (BBB) and prevents efficient passage of can …
Even though the BBTB is considered 'leaky' in the core part of glioblastomas, in large parts of glioblastomas and, even more s …
Biomarkers for immunotherapy for treatment of glioblastoma.
Lynes JP, Nwankwo AK, Sur HP, Sanchez VE, Sarpong KA, Ariyo OI, Dominah GA, Nduom EK. Lynes JP, et al. J Immunother Cancer. 2020 May;8(1):e000348. doi: 10.1136/jitc-2019-000348. J Immunother Cancer. 2020. PMID: 32474411 Free PMC article. Review.
Immunotherapy is a promising new therapeutic field that has demonstrated significant benefits in many solid-tumor malignancies, such as metastatic melanoma and non-small cell lung cancer. ...There are many clinical trials testing immune therapies in GB …
Immunotherapy is a promising new therapeutic field that has demonstrated significant benefits in many solid-tumor malignancies, such …
Pharmacotherapeutic Treatment of Glioblastoma: Where Are We to Date?
Gatto L, Di Nunno V, Franceschi E, Tosoni A, Bartolini S, Brandes AA. Gatto L, et al. Drugs. 2022 Apr;82(5):491-510. doi: 10.1007/s40265-022-01702-6. Epub 2022 Apr 9. Drugs. 2022. PMID: 35397073 Review.
The clinical management of glioblastoma (GBM) is still bereft of treatments able to significantly improve the poor prognosis of the disease. Despite the extreme clinical need for novel therapeutic drugs, only a small percentage of patients with GBM benefit fr …
The clinical management of glioblastoma (GBM) is still bereft of treatments able to significantly improve the poor prognosis of the d …
If it is Not a Glioblastoma, Then What is it? A Differential Diagnostic Review.
Gokden M. Gokden M. Adv Anat Pathol. 2017 Nov;24(6):379-391. doi: 10.1097/PAP.0000000000000170. Adv Anat Pathol. 2017. PMID: 28885262 Review.
As its historical name glioblastoma multiforme implies, glioblastoma is a histologically diverse, World Health Organization grade IV astrocytic neoplasm. ...To provide an approach applicable to diagnostic practice, these discussions are grouped arbitrarily according …
As its historical name glioblastoma multiforme implies, glioblastoma is a histologically diverse, World Health Organization gr …
Assessment of technical and clinical utility of a bead-based flow cytometry platform for multiparametric phenotyping of CNS-derived extracellular vesicles.
Brahmer A, Geiß C, Lygeraki A, Neuberger E, Tzaridis T, Nguyen TT, Luessi F, Régnier-Vigouroux A, Hartmann G, Simon P, Endres K, Bittner S, Reiners KS, Krämer-Albers EM. Brahmer A, et al. Cell Commun Signal. 2023 Oct 6;21(1):276. doi: 10.1186/s12964-023-01308-9. Cell Commun Signal. 2023. PMID: 37803478 Free PMC article.
In addition, EVs were separated from blood samples of small cohorts of glioblastoma (GB), multiple sclerosis (MS) and Alzheimer's disease patients as well as healthy controls (HC) and subjected to the EV Neuro assay. ...Video Abstract. Extracellular vesicles (EVs) a …
In addition, EVs were separated from blood samples of small cohorts of glioblastoma (GB), multiple sclerosis (MS) and Alzheime …
Antibody-Drug Conjugates for the Treatment of Solid Tumors: Clinical Experience and Latest Developments.
Nagayama A, Ellisen LW, Chabner B, Bardia A. Nagayama A, et al. Target Oncol. 2017 Dec;12(6):719-739. doi: 10.1007/s11523-017-0535-0. Target Oncol. 2017. PMID: 29116596 Review.
Antibody-drug conjugates (ADCs) are complex immunoconjugates designed to selectively deliver toxic small molecules preferentially to cancer cells. These immunoconjugates consist of a monoclonal antibody - directed to a tumor antigen - and a cytotoxic agent that is c …
Antibody-drug conjugates (ADCs) are complex immunoconjugates designed to selectively deliver toxic small molecules preferentially to …
A cell type-selective apoptosis-inducing small molecule for the treatment of brain cancer.
Lucki NC, Villa GR, Vergani N, Bollong MJ, Beyer BA, Lee JW, Anglin JL, Spangenberg SH, Chin EN, Sharma A, Johnson K, Sander PN, Gordon P, Skirboll SL, Wurdak H, Schultz PG, Mischel PS, Lairson LL. Lucki NC, et al. Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):6435-6440. doi: 10.1073/pnas.1816626116. Epub 2019 Mar 7. Proc Natl Acad Sci U S A. 2019. PMID: 30846550 Free PMC article.
A subpopulation of multipotent cells termed GBM cancer stem cells (CSCs) play a critical role in tumor initiation, tumor maintenance, metastasis, drug resistance, and recurrence following surgery. Here we report the identification of a small molecule, termed …
A subpopulation of multipotent cells termed GBM cancer stem cells (CSCs) play a critical role in tumor initiation, tumor maint …
114 results